Reaction Details |
| Report a problem with these data |
Target | Coagulation factor X |
---|
Ligand | BDBM607591 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro Testing of Human Factor Xa Assay |
---|
IC50 | 48.0±n/a nM |
---|
Citation | Mueller, SG; Allers, K; Klinder, K; Mueller-Vieira, U; Priepke, H; Pautsch, A 2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament US Patent US11691960 Publication Date 7/4/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Coagulation factor X |
---|
Name: | Coagulation factor X |
Synonyms: | Activated coagulation factor X (FXa) | Activated factor Xa heavy chain | Coagulation factor X precursor | Coagulation factor Xa | F10 | FA10_HUMAN | Factor X heavy chain | Factor X light chain | Factor Xa | Stuart factor | Stuart-Prower factor |
Type: | Enzyme |
Mol. Mass.: | 54726.60 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 488 |
Sequence: | MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEE
TCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKN
CELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR
KRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQE
CKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGE
AVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGI
VSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSG
GPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPE
VITSSPLK
|
|
|
BDBM607591 |
---|
n/a |
---|
Name | BDBM607591 |
Synonyms: | 5-ethynyl-N-(3,3,3-trifluoro-2-((3-methyl-4-(3-oxomorpholino)phenyl)carbamoyl)propyl)thiophene-2-carboxamide | US11691960, Example WO2006/034822 |
Type | Small organic molecule |
Emp. Form. | C22H20F3N3O4S |
Mol. Mass. | 479.472 |
SMILES | Cc1cc(NC(=O)C(CNC(=O)c2ccc(s2)C#C)C(F)(F)F)ccc1N1CCOCC1=O |
Structure |
|